Pharma News, 2020

US regulators have approved AstraZeneca’s Farxiga (dapagliflozin) to cut the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (...

Alexion Pharmaceuticals Inc.

Crescendo Biologics and Cancer Research UK have entered into a Clinical Development Partnership to progress one of Crescendo’s novel bispecific Humabody immunotherapies, CB213, into clinical trials ...

Shares in Newron Pharmaceuticals have taken a massive hit from the failure of sarizotan to show a clear benefit in patients with Rett syndrome, a severe neurodevelopmental disorder primarily affecting...

Menarini is to purchase Stemline Therapeutics in a deal valued at up to $677 million, establishing its presence in the US biopharma market.

European regulators have approved a label update for AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) to include a dosing regimen specifically to treat hyperkalaemia in patients with e...

Vicore Pharma has been given the green light by the UK's Medicines and Healthcare products Regulatory Agency (MHRA) to start a Phase II clinical trial assessing a potential COVID-19 therap...

The Food and Drug Administration on Friday granted an emergency use authorization to Gilead Sciences Inc.

The European Medicines Agency's human medicines committee (CHMP) has put forward eight medicines for approval at its April meeting.

Somerset, N.

Dozens of drug candidates are being floated as possible therapies for COVID-19, but manufacturing a successful candidate on a mass scale won't be easy.

India, one of the largest drug exporters in the world, has been hit hard by the novel coronavirus pandemic as global lockdowns have complicated daily operations.